FrancophonIA/ELRC3.0 huggingface dataset:
English: The results of a meta-analysis of 14 clinical trials with data from over 4700 patients treated with capecitabine showed that in all studies combined, female gender was statistically significantly associated with an increased risk of developing HFS and diarrhoea and with a decreased risk of developing neutropenia.
Danish: Resultaterne fra en metaanalyse af 14 kliniske studier med data fra mere end 4.700 patienter, som er blevet behandlet med capecitabin, viste, at i alle studier kombineret, var kvindeligt køn statistisk signifikant associeret med en øget risiko for udviklingen af hånd- og fodsyndrom og diarré og med en faldende risiko for at udvikle neutropeni.
English: Headache, Lethargy, Dizziness, Paraesthesia, Dysgeusia
Danish: Hovedpine, Sløvhed, Svimmelhed, Paræstesi, Dysgeusi
English: Hazard ratio 95% CI P value
Danish: Hazard ratio konfidensinterval p-værdi
English: Bone marrow depression, +Febrile Neutropenia
Danish: Knoglemarvsdepression, febril neutropeni
English: In the allrandomised population, capecitabine was shown to be superior to 5-FU/LV for disease-free survival (hazard ratio 0.849; 95% CI 0.739-0.976; p = 0.0212), as well as for overall survival (hazard ratio 0.828; 95% CI 0.705-0.971; p = 0.0203).
Danish: I den samlede randomiseringspopulation blev capecitabin vist at være bedre end 5-FU/LV mht. sygdomsfri overlevelse (hazard ratio 0,849; 95% konfidensinterval 0,739 - 0,976; p=0,0212) og mht. samlet overlevelse (hazard ratio 0,828; 95% konfidensinterval 0,705 - 0,971; p=0,0203).
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 20 April 2012
Danish: DATO FOR FØRSTE MARKEDSFØRINGSTILLADELSE/FORNYELSE AF TILLADELSEN
English: For Arm B, the XELIRI regimen used capecitabine 1000 mg/m2 twice daily for 14 days +irinotecan 250 mg/m2 on day 1.
Danish: I arm-B bestod det anvendte XELIRI-regime af 1.000 mg/m2 capecitabin 2 gange dagligt i 14 dage plus 250 mg/m2 irinotecan på dag 1.
English: fungal infections (including those of the mouth), influenza, gastroenteritis, tooth abscess
Danish: svampeinfektioner (herunder i munden), influenza, mave-tarm-infektion, tandbyld, knuder under huden (lipom)
English: Lower limb oedema, Hypertension, +Embolism and thrombosis
Danish: Vaskulære sygdomme Ødem i underekstremiteter, hypertension, +embolisme og tromboser
English: When capecitabine was used in combination with other medicinal products, elderly patients (≥65 years) experienced more grade 3 and grade 4 adverse drug reactions, including those leading to discontinuation, compared to younger patients.
Danish: Ældre patienter (≥ 65 år) havde, sammenlignet med yngre patienter, flere bivirkninger af grad 3 og 4, inklusive dem, som førte til seponering, når capecitabin blev anvendt i kombination med andre lægemidler.
English: In lactating mice, considerable amounts of capecitabine and its metabolites were found in milk.
Danish: Der er fundet betragtelige koncentrationer af capecitabin og dets metabolitter i mælken hos diegivende mus.
English: Uncommon side-effects (may affect up to 1 in 100 people) include:
Danish: Ikke almindelige bivirkninger (kan forekomme hos op til 1 ud af 100 patienter) omfatter:
English: These side effects can become severe; therefore, it is important that you always contact your doctor immediately when you start to experience a side effect.
Danish: Derfor skal du altid kontakte lægen, så snart du får en bivirkning.
English: Monotherapy with capecitabine in metastatic colorectal cancer Data from two identically-designed, multicentre, randomised, controlled phase III clinical trials (SO14695; SO14796) support the use of capecitabine for first line treatment of metastatic colorectal cancer.
Danish: Monoterapi med capecitabin i metastatisk kolorektalkræft Data fra to identisk designede, randomiserede, kontrollerede, kliniske multicenterstudier i fase III (SO14695; SO14796) støtter anvendelsen af capecitabin til 1. linjebehandling af metastatisk kolorektalkræft.
English: Patients should be carefully monitored for ophthalmological complications such as keratitis and corneal disorders, especially if they have a prior history of eye disorders.
Danish: Patienter bør monitoreres omhyggeligt for oftalmologiske komplikationer såsom keratitis og sygdomme på cornea.
English: Median progression-free survival (PFS) was 10.0 and 8.9 months; p=0.64, overall survival 25.7 and 27.5 months; p=0.55 and response rates 45.5 and 39.8%; p=0.32 for FOLFIRI-Bev and XELIRI-Bev, respectively.
Danish: For henholdsvis FOLFIRI plus bevacizumab og XELIRI plus bevacizumab var den mediane progressionfri overlevelse 10,0 og 8,9 måneder; p = 0,64, samlet overlevelse var 25,7 og 27,5 måneder; p = 0,55, og responsrater 45,5 % og 39,8 %; p = 0,32.
English: Grade 4
Danish: Se punkt 4.
English: Brivudine
Danish: Brivudin
English: (n=18) had about 36% lower Cmax and 24% lower AUC for capecitabine than Caucasian patients (n=22).
Danish: Efter oral administration af 825 mg/m2 capecitabin to gange dagligt i 14 dage, havde patienter af japansk oprindelse (n=18) omkring 36 % lavere Cmax og 24 % lavere AUC for capecitabin end patienter af kaukasisk oprindelse (n=22).
English: Capecitabine Teva may make you feel dizzy, nauseous or tired.
Danish: Capecitabine Teva kan forårsage svimmelhed, kvalme eller træthed.
English: In the all-randomised population, tests for difference of capecitabine vs 5-FU/LV in disease-free and overall survival showed hazard ratios of 0.88 (95% CI 0.77-1.01; p = 0.068) and 0.86 (95% CI 0.74-1.01; p = 0.060), respectively.
Danish: I testene hos den samlede randomiseringspopulation for forskel mellem capecitabin og 5-FU/LV mht. sygdomsfri og samlet overlevelse var hazard ratios hhv. 0,88 (95 % konfidensinterval 0,77 - 1,01; p=0,068) og 0,86 (95 % konfidensinterval 0,74 - 1,01; p=0,060).
English: • sweating, night sweats
Danish: • svedtendens, nattesved
English: Lacrimation increased Visual disorders, Dry eye, Eye pain, Visual impairment, Vision blurred
Danish: Synsforstyrrelser, tørre øjne, øjensmerter, synsnedsættelse, sløret syn
English: In this trial, 160 patients were randomised to treatment with capecitabine (1000 mg/m2 twice daily for 2 weeks followed by a 7-day rest period) and cisplatin (80 mg/m2 as a 2-hour infusion every 3 weeks).
Danish: I dette studie blev 160 patienter randomisered til behandling med capecitabin (1.000 mg/m2 to gange dagligt i 2 uger efterfulgt af 7 dages pause) og cisplatin (80 mg/m2 som en 2timers infusion hver 3. uge).
English: Table 4 Summary of related ADRs reported in patients treated with capecitabine monotherapy Body System Very Common All grades
Danish: Tabel 4 Sammenfatning af relaterede bivirkninger, som blev rapporteret hos patienter behandlet med capecitabin-monoterapi
English: In this trial, 1987 patients were randomised to treatment with capecitabine (1250 mg/m2 twice daily for 2 weeks followed by a 1-week rest period and given as 3week cycles for 24 weeks) or 5-FU and leucovorin (Mayo Clinic regimen: 20 mg/m2 leucovorin IV followed by 425 mg/m2 intravenous bolus 5-FU, on days 1 to 5, every 28 days for 24 weeks).
Danish: I dette studie blev 1.987 patienter randomiseret til behandling med capecitabin (1.250 mg/m2 to gange dagligt i 2 uger, efterfulgt af en uges pause, givet som 3-ugers serier i 24 uger) eller til behandling med 5-FU og leucovorin (Mayo Clinic-regime: 20 mg/m2 leucovorin i.v., efterfulgt af 425 mg/m2 intravenøs 5-FU som bolus på dag 1 til 5, hver 28. dag i 24 uger).
English: Capecitabine Teva contains lactose
Danish: Capecitabine Teva indeholder lactose
English: Reduced dose 500 mg/m2
Danish: Reduceret dosis 500 mg/m2
English: • confusional state, panic attacks, depressed mood, decreased libido
Danish: • forvirring, panikanfald, nedtrykt sindsstemning, nedsat sexlyst
English: Atrial fibrillation, Cardiac ischaemia/infarction
Danish: Atrieflimren, iskæmisk hjertesygdom/infarkt
English: Contents of the pack and other information What Capecitabine Teva contains - The active substance is capecitabine.
Danish: Pakningsstørrelser og yderligere oplysninger Capecitabine Teva indeholder:
English: • skin rash, hair loss (alopecia), skin reddening, dry skin, itching (pruritus), skin discolouration,
Danish: • hududslæt, hårtab (alopeci), rødme i huden, tør hud, kløe (pruritus), misfarvning af huden, tab af hud, betændelse i huden, neglesygdom
English: PHARMACEUTICAL FORM AND CONTENTS 60 film-coated tablets
Danish: 60 filmovertrukne tabletter
English: Reduced dose 750 mg/m2
Danish: Reduceret dosis 750 mg/m2
English: The time to peak plasma concentrations (Tmax in hours) were 1.50, 2.00, 2.00, 2.00 and 3.34.
Danish: Tiden indtil peak-plasmakoncentrationen (Tmax, timer) var 1,50;
English: • Grade 2 -1st appearance
Danish: • Grad 2 Ved 1. forekomst
English: Combination treatment consisted of first-line capecitabine (1000 mg/m2 twice daily for 14 days) combined with irinotecan (250 mg /m2 on day 1) (XELIRI) and second-line capecitabine (1000 mg/m2 twice daily for 14 days) plus oxaliplatin (130 mg/m2 on day 1).
Danish: Kombinationsbehandlingen bestod af 1. linjebehandling med capecitabin (1.000 mg/m2 to gange daglig i 14 dage) kombineret med irinotecan (250 mg/m2 på dag 1) (XELIRI) og 2. linjebehandling med capecitabin (1.000 mg/m2 to gange dagligt i 14 dage) plus oxaliplatin (130 mg/m2 på dag 1).
English: MARKETING AUTHORISATION NUMBER(S) EU/1/12/761/002
Danish: EU/1/12/761/002
English: PHARMACEUTICAL FORM AND CONTENTS 120 film-coated tablets
Danish: 120 filmovertrukne tabletter
English: Gastrointestinal haemorrhage, Constipation, Upper abdominal pain, Dyspepsia, Flatulence, Dry mouth
Danish: Gastrointestina l blødning, Konstipation, Øvre abdominale smerter, Dyspepsi, Flatulens, Mundtørhed
English: Increased phenytoin plasma concentrations resulting in symptoms of phenytoin intoxication in single cases have been reported during concomitant use of capecitabine with phenytoin.
Danish: I enkelte tilfælde er der, under samtidig behandling med capecitabin og phenytoin, rapporteret om stigninger i plasmakoncentrationerne af phenytoin, som har medført symptomer på fenytoinintoksikation.
English: Rare side effects (may affect up to 1 in 1,000 people) include:
Danish: Sjældne bivirkninger (kan forekomme hos op til 1 ud af 1.000 personer)
English: Folinic acid/folic acid
Danish: Folinsyre/folsyre
English: B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2) .
Danish: Lægemidlet må kun udleveres efter ordination på en særlig recept udstedt af en begrænset lægegruppe (se bilag I: Produktresumé, pkt.
English: • severe skin reaction such as skin rash, ulceration and blistering which may involve ulcers of the mouth, nose, genitalia, hands, feet and eyes (red and swollen eyes)
Danish: Meget sjældne bivirkninger (kan forekomme hos op til 1 ud af 10.000 personer) - svære hudreaktioner såsom hududslæt, sårdannelse og blæredannelse, som kan give sår i munden, næsen, kønsorganer, hænder, fødder og øjne (røde og opsvulmede øjne).
English: Administration of capecitabine should be interrupted if treatmentrelated elevations in bilirubin of >3.0 x ULN or treatment-related elevations in hepatic aminotransferases (ALT, AST) of >2.5 x ULN occur.
Danish: Hvis der forekommer behandlingsrelaterede stigninger af bilirubin > 3,0 x UNL eller af hepatiske aminotransferaser (ALAT og ASAT) > 2,5 x UNL skal behandlingen med capecitabin straks afbrydes.
English: You must not breast-feed if you are taking Capecitabine Teva and for 2 weeks after the last dose.
Danish: Du må ikke tage Capecitabine Teva, hvis du er gravid, eller tror du er det. Du må ikke amme, hvis du tager Capecitabine Teva og i 2 uger efter sidste dosis.
English: Lacrimal duct stenosis (rare), Corneal disorders(rare), keratitis (rare), punctate keratitis (rare)
Danish: Stenosis canaliculus lacrimalis (sjælden), Hornhinde-sygdom (sjælden), Keratitis (sjælden), Punktat keratitis (sjælden)
English: In patients with unrecognised DPD deficiency treated with capecitabine as well as in those patients who test negative for specific DPYD variations, life-threatening toxicities manifesting as acute overdose may occur (see section 4.9).
Danish: Livstruende toksicitet, der manifesterer sig som akut overdosis, kan forekomme hos patienter med uopdaget DPDmangel ved behandling med capecitabin samt hos de patienter, der testes negative for specifikke DPYD-variationer (se pkt.
English: In this trial, 255 patients were randomised to treatment with capecitabine (1250 mg/m2 twice daily for 2 weeks followed by 1-week rest period and docetaxel 75 mg/m2 as a 1 hour intravenous infusion every 3 weeks).
Danish: I dette studie randomiseredes 255 patienter til behandling med capecitabin (1.250 mg/m2 to gange dagligt i 2 uger efterfulgt af en uges pause og behandling med docetaxel 75 mg/m2 som 1 times intravøs infusion hver 3. uge).
English: Pain in jaw , Muscle spasms, Trismus, Muscular weakness
Danish: Kæbesmerter, muskelspasmer, trismus, muskelsvaghed
English: • Grade 4 -1st appearance
Danish: • Grad 4 Ved 1. forekomst
English: Sequential treatment consisted of first-line capecitabine (1250 mg/m2 twice daily for 14 days), second-line irinotecan (350 mg/m2 on day 1), and third-line combination of capecitabine (1000 mg/m2 twice daily for 14 days) with oxaliplatin (130 mg/m2 on day 1).
Danish: Den sekventielle behandling bestod af 1. linjebehandling med capecitabin (1.250 mg/m2 to gange daglig i 14 dage), 2. linjebehandling med irinotecan (350 mg/m2 på dag 1) og 3. linjebehandling en kombination af capecitabin (1.000 mg/m2 2 gange dagligt i 14 dage) med oxaliplatin (130 mg/m2 på dag 1).
English: Palmar-plantar erythrodysaesthesi a syndrome**
Danish: Toksicitet graduering*
English: • nerve pain
Danish: • nervesmerter
English: • Grade 3 -1st appearance
Danish: • Grad 3 Ved 1. forekomst
English: The film-coated tablets are oval biconvex light peach, 11.5 mm x 5.4 mm with inscription “C” on one side and “150”on the other side.
Danish: Capecitabine Teva 150 mg filmovertrukne tabletter De filmovertrukne tabletter er ovale bikonvekse, lys ferskenfarvede, 11,5 mm x 5,4 mm præget med “C” på den ene side og “150”på den anden.
English: MARKETING AUTHORISATION NUMBER(S) EU/1/12/761/001
Danish: EU/1/12/761/001
English: If the calculated creatinine clearance decreases during treatment to a value below 30 ml/min, Capecitabine Teva should be discontinued.
Danish: Capecitabine Teva bør seponeres, hvis den beregnede creatininclearance under behandling falder til et niveau under 30 ml/min.
English: The film-coated tablets are oval biconvex light peach, 16.0 mm x 8.5 mm with inscription “C” on one side and “500”on the other side.
Danish: Capecitabine Teva 500 mg filmovertrukne tabletter De filmovertrukne tabletter er ovale bikonvekse, lys ferskenfarvede, 16,0 mm x 8,5 mm præget med “C” på den ene side og “500”på den anden.
English: Table 2 Standard and reduced dose calculations according to body surface area for a starting dose of capecitabine of 1000 mg/m2
Danish: Tabel 2 Standard og reducerede dosisberegninger ud fra legemsoverfladeareal for en capecitabininitial dosis på 1.000 mg/m2 Dosisniveau på 1000 mg/m2 (to gange dagligt) Fuld dosis 1000 mg/m2
English: Capecitabine Teva contains sodium
Danish: Capecitabine Teva indeholder natrium
English: Тел: +359 24899585
Danish: България Актавис ЕАД Тел: +359 24899585
English: Oedema, Chills,
Danish: Atrieflimmer, Arytmi,
English: Capecitabine Teva 500 mg film-coated tablets Each film-coated tablet contains 52.0 mg lactose.
Danish: Capecitabine Teva 500 mg filmovertrukne tabletter Hver filmovertrukket tablet indeholder 52,0 mg lactose.
English: How to take Capecitabine Teva
Danish: Sådan skal du tage Capecitabine Teva
English: Hypertension,
Danish: Kulderystelser,
English: Hypomagnesaemia,
Danish: Hyperbilirubin æmi,
English: • DPD Deficiency: if you have a known DPD deficiency, you are at an increased risk of acute early-onset of toxicity and severe, life-threatening, or fatal adverse reactions caused by Capecitabine Teva (e.g. stomatitis, mucosal inflammation, diarrhoea, neutropenia, and neurotoxicity).
Danish: • DPD-mangel: hvis du ved, at du har DPD-mangel, har du en øget risiko for akut tidlig indtræden af bivirkninger og svære, livstruende eller dødelige bivirkninger forårsaget af
English: • bleeding from the gut, constipation, pain in upper abdomen, indigestion, excess wind, dry mouth
Danish: • blødning fra tarmen, forstoppelse, smerter i den øverste del af maven, luft i maven, mundtørhed
English: Sore throat, Dysaesthesia pharynx
Danish: Ondt i halsen, pharynxdysæstesi
English: Table 8 Key efficacy results for AIO KRK study XELOX + bevacizumab
Danish: Tabel 8 Nøgleresultater for virkning fra AIO KRK-studiet
English: • Hand-and-foot skin-reaction: if you have pain, swelling, redness or tingling of hands and/or feet
Danish: • Hudsymptomer på hænder og fødder: hvis du har smerter, hævelse, rødme eller prikken i
English: • vein inflammation
Danish: • betændelse i vener
English: Neurotoxicity, Tremor, Neuralgia,
Danish: Neurotoksicitet, tremor, neuralgi, hypersensitivitetsreaktio ner, hypoæstesi
English: • Recent or concomitant treatment with brivudine (see section 4.4 and 4.5 for drug-drug interaction),
Danish: • Nylig eller samtidig behandling med brivudin (se pkt.
English: - ECF: epirubicin (50 mg/m2 as a bolus on day 1 every 3 weeks), cisplatin (60 mg/m2 as a two hour infusion on day 1 every 3 weeks) and 5-FU (200 mg/m2 daily given by continuous infusion via a central line).
Danish: - ECF: epirubicin (50 mg/m2 som bolus på dag 1 hver 3. uge), cisplatin (60 mg/m2 som en totimers infusion på dag 1 hver 3. uge) og 5-FU (200 mg/m2 dagligt givet som kontinuerlig infusion via et centralt venekateter)
English: Encephalopathy
Danish: Vaskulære sygdomme
English: • narrowing or blockage of tear duct (lacrimal duct stenosis)
Danish: • forsnævring eller blokering af tårekanalen
English: - EOX: epirubicin (50 mg/m2 as a bolus on day 1 every 3 weeks), oxaliplatin (130 mg/m2 given as a 2 hour infusion on day 1 every three weeks), and capecitabine (625 mg/m2 twice daily continuously).
Danish: - EOX: epirubicin (50 mg/m2 som bolus på dag 1 hver 3. uge), oxaliplatin (130 mg/m2 som en totimers infusion på dag 1 hver 3. uge) og capecitabin (625 mg/m2 to gange dagligt givet kontinuerligt).
English: 120 Patients were randomised to a modified XELIRI regimen with capecitabine 800 mg/m2 twice daily for two weeks followed by a 7-day rest period), irinotecan (200 mg/m2 as a 30 minute infusion on day 1 every 3 weeks), and bevacizumab (7.5 mg/kg as a 30 to 90 minute infusion on day 1 every 3 weeks) ; 127 patients were randomised to treatment with capecitabine (1000 mg/m2 twice daily for two weeks followed by a 7-day rest period), oxaliplatin (130 mg/m2 as a 2 hour infusion on day 1 every 3 weeks), and bevacizumab (7.5 mg/kg as a 30 to 90 minute infusion on day 1 every 3 weeks).
Danish: 120 patienter blev randomiseret til at få et modficeret XELIRI-regime med capecitabin (800 mg/m2 2 gange dagligt i to uger efterfulgt af 7 dages pause), irinotecan (200 mg/m2 som infusion over 30 minutter på dag 1 hver tredje uge) og bevacizumab (7,5 mg/kg som infusion over 30 til 90 minutter på dag 1 hver tredje uge).
English: Deficiency of DPD may lead to increased toxicity of capecitabine (see section 4.3 and
Danish: Dihydropyrimidindehydrogenase (DPD) aktiviteten er det hastighedsbestemmende trin. DPD deficit kan medføre øget toksicitet af capecitabin (se pkt.
English: What you need to know before you take Capecitabine Teva
Danish: Det skal du vide, før du begynder at tage Capecitabine Teva Tag ikke Capecitabine Teva
English: 400 mg/m2 intravenous bolus, followed by 600 mg/m2 intravenous 22 hr
Danish: 5-Fluorouracil 400 mg/m2 intravenøs bolus, efterfulgt af
English: The hazard ratio for overall survival was 0.94 (95% CI: 0.89; 1.00, p=0.0489) indicating that capecitabine-containing regimens are noninferior to 5-FU-containing regimens.
Danish: Hazard ratio for samlet overlevelse var 0,94 (95 % konfidensinterval: 0,89; 1,00: p=0,0489).
English: Rash, Alopecia, Erythema, Dry skin, Pruritus, Skin hyperpigmentatio n, Rash macular, Skin desquamation, Dermatitis, Pigmentation disorder, Nail disorder
Danish: Udslæt, Alopeci, Erythem, Tør hud, Pruritus, Hyperpigment ering af huden, Makuløst udslæt,
English: Diarrhoea (see section 4.4)
Danish: Diarré (se pkt.
English: Table 1 Standard and reduced dose calculations according to body surface area for a starting dose of capecitabine of 1250 mg/m2
Danish: Capecitabine Teva-dosisberegninger Tabel 1 Standard og reducerede dosisberegninger ud fra legemsoverfladeareal for en capecitabininitial dosis på 1250 mg/m2 Dosisniveau på 1250 mg/m2 (to gange dagligt) Fuld dosis 1250 mg/m2
English: Cardiotoxicity (see section 4.4)
Danish: Kardiotoksicitet (se pkt.
English: Oxaliplatin 130 mg/m2 intravenous 2 hr
Danish: 130 mg/m2 intravenøs 2 timer
English: - Capecitabine Teva 500 mg film-coated tablets Each film-coated tablet contains 500 mg capecitabine.
Danish: - Capecitabine Teva 500 mg filmovertrukne tabletter Hver filmovertrukket tablet indeholder 500 mg capecitabin.
English: Capecitabine Teva 500 mg film-coated tablets
Danish: Capecitabine Teva 500 mg filmovertrukne tabletter
English: Oesophagitis, Abdominal discomfort, Gastrooesophagea l reflux disease, Colitis, Blood in stool
Danish: Gastroøsofageal reflux, Colitis, Blod i afføringen
English: Capecitabine Teva 500 mg film-coated tablets Each film-coated tablet contains 500 mg capecitabine.
Danish: Capecitabine Teva 500 mg filmovertrukne tabletter Hver filmovertrukket tablet indeholder 500 mg capecitabin.
English: weeks, a frequency of 22% to 30% of all-grade HFS was observed in capecitabine combination therapy.
Danish: For en capecitabindosis på 1.000 mg/m2 to gange daglig på dagene 1 til 14 hver 3. uge blev der observeret hånd- og fodsyndrom i alle grader med en hyppighed på 22 % til 30 % i capecitabin-kombinationsbehandling.
English: - Capecitabine Teva 150 mg film-coated tablets
Danish: - Capecitabine Teva 150 mg filmovertrukne tabletter
English: What you need to know before you take Capecitabine Teva 3.
Danish: Det skal du vide, før du begynder at tage Capecitabine Teva Sådan skal du tage Capecitabine Teva Bivirkninger
English: Dyspnoea, Epistaxis, Cough, Rhinorrhoea
Danish: Dyspnø, Epistaxis, Hoste, Rindende næse
English: Aphasia, Memory impairment, Ataxia, Syncope, Balance disorder, Sensory disorder, Neuropathy peripheral
Danish: Hukommelsessv ækkelse Ataksi, Synkope, Balanceforstyrre lser,
English: fluoro-ureidopropionic acid (FUPA).
Danish: Dihydropyrimidinase spalter pyrimidinringen til 5-fluoro ureidopropionsyre (FUPA).
English: • bowel obstruction, collection of fluid in the abdomen, inflammation of the small or large intestine, the stomach or the oesophagus, pain in the lower abdomen, abdominal discomfort,
Danish: • blokering af tarmen, ophobning af væske i maven, betændelse i tynd- og tyktarm, maven eller spiserøret, smerter i den nedre del af maven, ubehag i maven, halsbrand (tilbageløb af mad fra maven), blod i afføringen
English: Full dose
Danish: Leverinsufficiens
English: 53% to 60% of all-grades HFS was observed in capecitabine monotherapy trials (comprising studies in adjuvant therapy in colon cancer, treatment of metastatic colorectal cancer, and treatment of breast cancer) and a frequency of 63% was observed in the capecitabine/docetaxel arm for the treatment of metastatic breast cancer.
Danish: For capecitabindosis på 1.250 mg/m2 to gange dagligt på dagene 1 til 14 hver 3. uge blev der observeret hånd- og fodsyndrom i alle grader med en hyppighed på 53 % til 60 % i cabecitabinmonoterapistudierne (bestående af studier i adjuverende behandling af kolonkræft, behandling af metastatisk kolorektalkræft og behandling af brystkræft).
English: Oval biconvex light peach film-coated tablets with inscription “C” on one side and “150” on the other side.
Danish: Capecitabine Teva 150 mg filmovertrukne tabletter Ovale, bikonvekse, lys ferskenfarvede filmovertrukne tabletter præget med “C” på den ene side og “150” på den anden.
English: Very Common All grades
Danish: Meget almindelig
English: Diabetes, Hypokalaemia, Appetite disorder, Malnutrition, Hypertriglycerida emia
Danish: Diabetes, Hypokaliæmi, Appetitforstyrrel ser,